NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
4.200
-0.780 (-15.66%)
At close: Nov 26, 2025, 4:00 PM EST
4.108
-0.092 (-2.20%)
After-hours: Nov 26, 2025, 7:08 PM EST
NanoVibronix Market Cap
NanoVibronix has a market cap or net worth of $4.57 million as of November 26, 2025. Its market cap has increased by 87.67% in one year.
Market Cap
4.57M
Enterprise Value
790.34K
1-Year Change
87.67%
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since May 28, 2015, NanoVibronix's market cap has decreased from $6.43B to $4.57M, a decrease of -99.93%. That is a compound annual growth rate of -49.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 5.42M | 144.78% |
| Dec 31, 2024 | 2.21M | -5.92% |
| Dec 29, 2023 | 2.35M | -71.52% |
| Dec 30, 2022 | 8.26M | -97.82% |
| Dec 31, 2021 | 379.13M | -91.52% |
| Dec 31, 2020 | 4.47B | -76.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 953.07B |
| Johnson & Johnson | 493.64B |
| AbbVie | 406.90B |
| UnitedHealth Group | 290.35B |
| AstraZeneca | 283.06B |
| Merck & Co. | 251.83B |
| Novartis AG | 243.93B |
| Abbott Laboratories | 223.55B |